Lasa Supergenerics P/E Ratio
Lasa Supergenerics (LASA) P/E ratio is not applicable — EPS (TTM) ₹-2.95. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-2.95
Healthcare Peers with Valid P/E Ratios — LASA Comparison
Healthcare sector average P/E 49.25, median 27.32 — LASA excluded (negative EPS).
Sector Average PE
49.25
Sector Median PE
27.32
Lowest PE
1.17
Profitable Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 6.78 | ₹73 | Low |
| Zenith Drugs | ZENITHDRUG | 7.55 | ₹73 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Medicamen Organics | MEDIORG | 8.01 | ₹32 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Vasundhara Rasayans | VRL | 11.05 | ₹40 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see LASA stock price BSE.
- Analyse Lasa Supergenerics shareholding analysis to track promoter, FII and institutional holdings.
- View LASA 52-week high low for the annual high/low range and current price position.